Most of the frequently found somatic mutations in low-flow vascular malformations occur in genes involved in the mammalian target of rapamycin (mTOR) pathway; for example, PIK3CA and TEK/TIE-2 mutations lead to a gain of function and increased activity of mTOR (3–7). The gene discussed is TEK; the disease is vascular malformation.